JP Morgan Private Wealth Advisors’s PLx Pharma PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-29,962
Closed -$19K – 2020
2022
Q3
$19K Sell
29,962
-23,165
-44% -$34.1K ﹤0.01% 1910
2022
Q2
$129K Sell
53,127
-126,100
-70% -$350K ﹤0.01% 1861
2022
Q1
$724K Sell
179,227
-104,290
-37% -$572K ﹤0.01% 1363
2021
Q4
$2.27M Buy
283,517
+69,862
+33% +$819K ﹤0.01% 858
2021
Q3
$4.12M Buy
213,655
+193,655
+968% +$3.38M 0.01% 644
2021
Q2
$276K Buy
+20,000
New +$237K ﹤0.01% 1700

Other funds holding PLXP

JP Morgan Private Wealth Advisors's PLXP Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of PLx Pharma (PLXP) in Q4 2022, closing a stake of 29,962 shares — an estimated $19K sold.

JP Morgan Private Wealth Advisors first reported a position in PLXP in Q2 2021 and held it in 6 quarters. The position peaked at $4.12M in Q3 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining PLx Pharma position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 29,962 PLx Pharma shares in Q4 2022, an estimated $19K.
  • JP Morgan Private Wealth Advisors first reported a position in PLx Pharma in Q2 2021 and held it in 6 quarters.
  • JP Morgan Private Wealth Advisors's PLx Pharma position peaked at $4.12M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held PLx Pharma as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.